Referencia

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10626-31. Epub 2010 May 24.

Autores

Vanessa Núñeza,1, Daniel Alamedaa,1, Daniel Ricoa,2, Rubén Motab, Pilar Gonzalob, Marta Cedenillaa, Thierry Fischerc, Lisardo Boscád, Christopher K. Glasse, Alicia G. Arroyob, and Mercedes Ricotea,3 Departments of aRegenerative Cardiology and bVascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain; cDepartment of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid 28049, Spain; dInstituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid 28029, Spain; and eDepartment of Medicine, Department of Cellular and Molecular Medicine, University of California,La Jolla, CA 92093 1V.N. and D.A. contributed equally to this work. 2Present address: Structural Biology and Biocomputing Programme, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain. 3To whom correspondence should be addressed. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it..

Resumen

En nuestro trabajo describimos el papel del receptor X de retinoides (RXR) en la función de los macrófagos durante procesos inflamatorios. RXR es miembro de la superfamilia de los receptores nucleares que son factores de transcripción activados por ligando. Para estudiar la función de RXR en macrófagos generamos un ratón knock-out para RXRα específico de la línea mieloide. Dichos ratones mostraron una disminución en la migración leucocitaria al foco de inflamación en modelos de peritonitis estéril y un incremento en la supervivencia en modelos de sepsis. Todo ello se correlacionó con una reducción en los niveles de las quimioquinas pro-inflamatorias CCL6 y CCL9. Además demostramos que estas quimioquinas están reguladas transcripcionalmente por RXR como homodimero. Nuestros resultados sugieren que RXR es una posible diana terapéutica para el tratamiento de enfermedades inflamatorias.

Descripción

Imagen artículo Julio

REFERENCIA DEL GRUPO Y/O INVESTIGADOR
Los receptores nucleares constituyen una superfamilia de factores de transcripción dependientes de ligando que regulan diferentes aspectos del crecimiento, el desarrollo y la homeostasis. Una de las principales cuestiones en el campo de los receptores nucleares es el descubrimiento de los mecanismos moleculares que median la activación y represión de los genes diana de estos receptores. El objetivo central del laboratorio de la Dra. Mercedes Ricote es elucidar los programas transcripcionales por los cuales estos receptores regulan la expresión génica en macrófagos y como estos patrones de expresión específicos podrían ser modulados para prevenir el desarrollo de enfermedades humanas, tales como obesidad, diabetes y enfermedades cardiovasculares. Para llevar a cabo estos estudios se utiliza una combinación de técnicas de biología molecular/celular, genómica, modelos animales in vivo, específicamente animales knockouts condicionales en macrófagos y tecnología de microarrays. En el trabajo recientemente publicado en Proceedings of the National Academy of Science se establece que el receptor X de retinoides (RXR) desempeña un papel importante en la respuesta innata. El resultado de nuestros experimentos demuestra que RXR es una potencial diana terapéutica para el tratamiento y prevención de la sepsis así como de otras enfermedades inflamatorias crónicas. Otras líneas de investigación del laboratorio exploran el papel de los receptores nucleares en las bases moleculares de la resistencia a la insulina y la aterosclerosis. Mercedes Ricote es investigadora del Centro Nacional de Investigaciones Cardiovasculares (CNIC).

Para ver el artículo completo, pulse aquí

Did you publish an interesting article recently?

Send it through our application form and we will contact you. Age limit: 32.

The selected articles will participate at the Award to the best article of young people of the SEBBM which will be given during SEBBM conference, that will take place at Spain (free registration, travel and accommodation).

More articles of the month

Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction

01-08-2019

Actinoporins are a group of soluble toxic proteins that bind to membranes containing sphingomyelin (SM) and oli- gomerize to form pores. Sticholysin II (StnII) is a member of the actinoporin...

Read more

Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

01-07-2019

To satisfy its high energetic demand, the brain depends on the metabolic cooperation of various cell types. For example, astrocytic-derived lactate sustains memory consolidation by serving both as an oxidizable...

Read more

Glucose restriction promotes osteocyte specification by activating a PGC-1α-dependent transcriptional program

03-06-2019

Osteocytes, the most abundant of bone cells, differentiate while they remain buried within the bone matrix. This encasement limits their access to nutrients and likely affects their differentiation, a process...

Read more

ParB dynamics and the critical role of the CTD in DNA condensation unveiled by combined force-fluorescence measurements

01-05-2019

/Bacillus subtilis/ ParB forms multimeric networks involving non-specific DNA binding leading to DNA condensation. Previously, we found that an excess of the free C-terminal domain (CTD) of ParB impeded DNA...

Read more

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

01-04-2019

Although human epidermal growth factor receptor 2 (HER2)-targeted therapies have dramatically improved the clinical outcome of HER2-positive breast cancer patients, innate and acquired resistance remains an important clinical challenge. New...

Read more

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton

01-03-2019

Planar cell polarity (PCP) and intercellular junctional complexes establish tissue structure and coordinated behaviors across epithelial sheets. In multiciliated ependymal cells, rotational and translational PCP coordinate cilia beating and direct...

Read more

β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9R239X mice

01-02-2019

Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In...

Read more

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

02-01-2019

Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons, a process that current therapeutic approaches cannot prevent. In PD, the typical pathological hallmark is the accumulation of...

Read more

Dynamic acetylation of cytosolic phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions

01-12-2018

Cytosolic phosphoenolpyruvate carboxykinase (PCK1) is considered a gluconeogenic enzyme; however, its metabolic functions and regulatory mechanisms beyond gluconeogenesis are poorly understood. Here, we describe that dynamic acetylation of PCK1 interconverts...

Read more

The Helicase PIF1 Facilitates Resection overSequences Prone to Forming G4 Structures

02-11-2018

DNA breaks are complex lesions that can be repaired either by non-homologous end joining (NHEJ) or by homologous recombination (HR). The decision between these two routes of DNA repair is...

Read more

Protector Members